Beratung und Therapie der Kinderwunschpatientin beim PCO-Syndrom

Conference paper

Zusammenfassung

  1. 1.

    Das PCO-Syndrom (PCOS) ist eine der häufigsten Endokrinopathien bei der Frau. 5–10% der Frauen in der Prämenopause sind hiervon betroffen. Bei 75% der anovulatorischen Sterilität ist das PCOS die pathogenetische Ursache.

     
  2. 2.

    Pathogenese: Insulinresistenz mit kompensatorischer Hyperinsulinämie, erhöhte LH-Pulsfrequenz/Amplitude → erhöhte Thekazell-/Stroma-Stimulation → erhöhte ovarielle Testosteron-/Androstendionbiosynthese/-sekretion; veränderter Androgenmetabolismus der Thekazellen; familiäre genetische Disposition zur Adipositas, Insulinresistenz, pathologischen ovariellen/adrenalen Androgenproduktion.

     
  3. 3.

    Diagnostik: a) Symptome: Zyklusstörungen, Hirsutismus, Akne; b) Ultraschall + Hormonanalyse; c) Insulin-/Glucosemetabolismus (Insulinresistenz?) insbesondere bei Adipositas.

     
  4. 4.

    Therapie: Gewichtsreduktion und Bewegung bei Adipositas; instabile Zyklen → Oligo/ Amenorrhoe: 1. Clomifen (CC): beginnend niedrig dosiert mit 25–50 mg/die, 2. kombinierte CC-/FSH-hMG-Therapie, 3.low dose FSH-hmg-Therapie; stimulationsresistente Ovarien: bei Insulinresistenz Basistherapie 1500 mg/die Metformin, evtl. ovarielle Punktkoagulation.

     
  5. 5.

    Wünschenswerte Perspektiven bei der Therapie von Patienten mit PCOS: Frühzeitige gynäkologische Diagnostik des PCOS; frühzeitige internistische Diagnostik der Insulinresistenz mit frühzeitiger Therapie: Verminderung der ovariellen Hyperandrogenämie; Verbesserung der Schwangerschaftsrate; Verminderung der Frühaborte; Verminderung der Adipositas; Verminderung der Entwicklung eines Diabetes mellitus; Verhinderung des metabolischen Syndroms (Hypertonus, Hyperlipidämie, kardiovaskuläre Erkrankung).

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams J, Polson DW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J Clin Res 293: 355–359CrossRefGoogle Scholar
  2. Amer SAK, Gopalan V, Li TC, Ledger WL, Cooke ID (2oo2) Long term follow-up of patients with poly-cystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome. Hum Reprod 17: 2035–2042Google Scholar
  3. Asunciόn M, Calvo RM, San Milldn JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women in Spain. J Clin Endocrinol Metab 85: 2434–2438CrossRefGoogle Scholar
  4. Clark AM, Ledger W, Galletly C (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10: 2705–2712PubMedCrossRefGoogle Scholar
  5. Clark AM, Thornley B, Tomlinson L, Galletley C, Nor-man RJ (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13: 15o2–15o5Google Scholar
  6. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the popula-tion? Clin Endocrinol 37: 127–134CrossRefGoogle Scholar
  7. Cohen J (2000) Laparoscopic surgical treatment of infertility related to polycystic ovary syndrome. In: Kovacs GT (ed) Polycystic ovary syndrome. Cam-bridge University Press, pp 144–158Google Scholar
  8. Cresswell JL, Barker DJ, Osmond C (1997) Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 35o: 1131–1135CrossRefGoogle Scholar
  9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filan-dra FA, Tsianateli TC, Spina GC, Zapanti ED, Bart-zis MI (1999) A survey of the polycystic ovary syn-drome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006–4011PubMedCrossRefGoogle Scholar
  10. Donesky B, Adashi E (1995) Surgically induced ovula-tion in the PCO syndrome: wedge resection revisi-ted. Fertil Steril 63: 439–463PubMedGoogle Scholar
  11. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18: 774–800PubMedCrossRefGoogle Scholar
  12. Franks S, Cela E, Gharani N, Waterworth D, McCarthy M (2000) The inheritance of polycystic ovary syndrome. In: Kovacs GT (ed) Polycystic ovary syndrome. Cambridge University Press, pp 23–34Google Scholar
  13. Gordon CM (1999) Menstrual disorders in adolescents: excess androgens and the polycystic ovary syndrome. Pediatr Clin North Am 46: 519–543PubMedCrossRefGoogle Scholar
  14. Govind A, Obhrai MS, Clayton RN (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84: 38–43Google Scholar
  15. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ (1994) Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 61: 598–604PubMedGoogle Scholar
  16. Holte J, Bergh T, Berne C, Wide L, Lithell H (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80: 2586–2593PubMedCrossRefGoogle Scholar
  17. Huber-Buchholz MM, Carey DGP, Norman RJ (1999) Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84: 1470–1474PubMedCrossRefGoogle Scholar
  18. Hugues JN, Cédrin-Durnerin I, Avril C, Bulwa S, Hervé F, Uzan M (1996) Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod 11: 2581–2584PubMedCrossRefGoogle Scholar
  19. Kiddy DS, Hamilton-Fairley D, Bush A (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36: 105–111CrossRefGoogle Scholar
  20. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the poly-cystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. J Clin Endocrinol Metab 83: 3078–3082PubMedCrossRefGoogle Scholar
  21. Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95: 14956–14960PubMedCrossRefGoogle Scholar
  22. Michelmore KF, Balen, AH, Dunger DB, Vessey MP (1999) Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 51: 779–786CrossRefGoogle Scholar
  23. Moran C, Knochenhauer E, Boots LR (1999) Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 71: 672–674CrossRefGoogle Scholar
  24. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med: 1876–1880Google Scholar
  25. Nestler JE, Stovall D, Akhter N, Iuomo MJ, Jakubowicz DJ (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with poly-cystic ovary syndrome. Fertil Steril 77: 209–215PubMedCrossRefGoogle Scholar
  26. Pettigrew R, Hamilton-Fairley D (1997) Obesity and female reproductive function. Br Med Bull 53: 341–358Google Scholar
  27. Poison DW, Adams J, Wadsworth J, Franks S (1988) Polycystic ovaries–a common finding in normal women. Lancet 1: 870–872Google Scholar
  28. Rosenfield RL (1999) Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 28: 265–293PubMedCrossRefGoogle Scholar
  29. Tayob Y, Robinson G, Adams J (1990) Ultrasound appearance of the ovaries during the pill-free interval. Br J Fam Plan 16: 94–96Google Scholar
  30. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75: 310–315PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Gips

There are no affiliations available

Personalised recommendations